title: MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1.
abstract: OBJECTIVE
  Five different types of maturity-onset diabetes of the young (MODY) have been identified until now but mutation screening suggests that more MODY genes exist. Mutations in genes encoding transcription factors essential for normal development and function of pancreatic beta cells has recently become important in studying the genetics of Type II (non-insulin-dependent) diabetes mellitus. Patients with MODY and their families in Iceland were screened for mutations in the transcription factor genes.
  
  
  METHODS
  Clinical and biochemical information on individuals with MODY was collected and their family trees constructed. Linkage analysis was carried out on chromosomal regions known to harbour genes previously shown to be associated with MODY. Mutations were identified by direct sequencing.
  
  
  RESULTS
  Three families were identified. Two of these showed linkage to chromosome 12 and carried mutations in exon 4 of the HNF-1alpha gene (290fsdelC and R272C). However, the third family showed no linkage to the previously described MODY genes but shared a novel mutation in the NeuroD1 gene on chromosome 2q32. This mutation, a glutamate to lysine substitution at codon 110, resides in the basic domain of the protein.
  
  
  CONCLUSIONS
  Mutations in MODY subjects have been identified in the Icelandic population. In addition this study identified the NeuroD1 gene as the gene responsible for the sixth type of MODY.
authors.affiliation: Unit of Medical Genetics, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
authors.forename: S Y
authors.initials: SY
authors.lastname: Kristinsson
authors.forename: E T
authors.initials: ET
authors.lastname: Thorolfsdottir
authors.forename: B
authors.initials: B
authors.lastname: Talseth
authors.forename: E
authors.initials: E
authors.lastname: Steingrimsson
authors.forename: A V
authors.initials: AV
authors.lastname: Thorsson
authors.forename: T
authors.initials: T
authors.lastname: Helgason
authors.forename: A B
authors.initials: AB
authors.lastname: Hreidarsson
authors.forename: R
authors.initials: R
authors.lastname: Arngrimsson
mesh_terms: D017668:Age of Onset; D001483:Base Sequence; D051792:Basic Helix-Loop-Helix Proteins; D004268:DNA-Binding Proteins / Q000235:genetics*; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D016640:Diabetes, Gestational / Q000235:genetics; D005260:Female; D005819:Genetic Markers; D005951:Glucose Tolerance Test; D051537:Hepatocyte Nuclear Factor 1; D051538:Hepatocyte Nuclear Factor 1-alpha; D051539:Hepatocyte Nuclear Factor 1-beta; D006801:Humans; D009154:Mutation; D009687:Nuclear Proteins; D010375:Pedigree; D011247:Pregnancy; D012016:Reference Values; D015534:Trans-Activators / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D051792:Basic Helix-Loop-Helix Proteins; D004268:DNA-Binding Proteins; D005819:Genetic Markers; D051537:Hepatocyte Nuclear Factor 1; D051538:Hepatocyte Nuclear Factor 1-alpha; D051539:Hepatocyte Nuclear Factor 1-beta; D009687:Nuclear Proteins; D015534:Trans-Activators; D014157:Transcription Factors; C496487:HNF1A protein, human; C496495:HNF1B protein, human; C093970:NEUROD1 protein, human